日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cross-comparison study of three ELISA methodologies to measure Shigella Sonnei O-antigen serum IgG

三种ELISA方法测定宋内氏志贺氏菌O抗原血清IgG的交叉比较研究

Stickings, Paul; Vipond, Caroline; Rigsby, Peter; Micoli, Francesca; Rossi, Omar; Mancini, Francesca; Conti, Valentino; Cohen, Dani; Bialik, Anya; Meron-Sudai, Shiri; Asato, Valeria; Clarkson, Kristen A; MacLennan, Calman A; Kaminski, Robert W

Landscape analysis of invasive non-typhoidal salmonella (iNTS) disease and iNTS vaccine use case and demand: Report of a WHO expert consultation

侵袭性非伤寒沙门氏菌(iNTS)疾病及iNTS疫苗使用情况和需求的现状分析:世卫组织专家磋商报告

Emary, Kate; Bentsi-Enchill, Adwoa D; Giersing, Birgitte K; Gordon, Melita; Dale, Helen; Chirwa, Esmelda B; Johnston, Peter; MacLennan, Calman A; Kariuki, Samuel; Excler, Jean-Louis; Kim, Jerome H; Kaminski, Robert W; Wilder-Smith, Annelies

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries

咨询报告——关于在流行国家使用二价伤寒/甲型副伤寒沙门氏菌疫苗的监管途径的考量

Ibarz-Pavon, Ana Belen; Bielsky, Marie-Christine; Bose, Rubina; Cavaleri, Marco; Crump, John A; Hombach, Joachim; Kaslow, David C; Khaman, Farhana; MacLennan, Calman A; Mehring-LeDoare, Kirsty; Pollard, Andrew J; Quadri, Firdausi; John, Jacob; Wilder-Smith, Annelies

Non-typhoidal Salmonella combination vaccines: clinical development plan and regulatory considerations

非伤寒沙门氏菌联合疫苗:临床开发计划和监管考量

Excler, Jean-Louis; Saluja, Tarun; Wilder-Smith, Annelies; Kaminski, Robert W; MacLennan, Calman A; Cavaleri, Marco; Kim, Jerome H

The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops

2022年志贺氏菌和产肠毒素大肠杆菌疫苗(VASE)会议:分组研讨会总结

Baqar, Shahida; Bonavia, Aurelio; Louis Bourgeois, A; Campo, Joseph J; Clifford, Allison; Hanevik, Kurt; Hasso-Agopsowicz, Mateusz; Hausdorff, William; Kaminski, Robert; MacLennan, Calman A; Mantis, Nicholas; Martin, Laura B; Omore, Richard; Pasetti, Marcela; Pavlinac, Patricia; Phalipon, Armelle; Poly, Frédéric; Porter, Chad; Ramasamy, Maheshi N; Rogawski McQuade, Elizabeth T; Sztein, Marcelo B; Walker, Richard

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries

针对低收入和中等收入国家5岁以下儿童的志贺氏菌疫苗的临床和监管开发策略

Giersing, Birgitte K; Isbrucker, Richard; Kaslow, David C; Cavaleri, Marco; Baylor, Norman; Maiga, Diadié; Pavlinac, Patricia B; Riddle, Mark S; Kang, Gagandeep; MacLennan, Calman A

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data

血清中针对志贺氏菌脂多糖的IgG保护阈值水平:志贺氏菌疫苗试验数据的重新分析

Cohen, Dani; Ashkenazi, Shai; Schneerson, Rachel; Farzam, Nahid; Bialik, Anya; Meron-Sudai, Shiri; Asato, Valeria; Goren, Sophy; Baran, Tomer Ziv; Muhsen, Khitam; Gilbert, Peter B; MacLennan, Calman A

Immune responses to Neisseria gonorrhoeae and implications for vaccine development

对淋病奈瑟菌的免疫反应及其对疫苗研发的影响

Belcher, Thomas; Rollier, Christine S; Dold, Christina; Ross, Jonathan D C; MacLennan, Calman A

Consequences of Shigella infection in young children: a systematic review

志贺氏菌感染对幼儿的影响:系统性综述

Libby, Tanya E; Delawalla, Miranda L M; Al-Shimari, Fatima; MacLennan, Calman A; Vannice, Kirsten S; Pavlinac, Patricia B

Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines

探索影响传统和创新型糖缀合物疫苗免疫反应的变量

Micoli, Francesca; Stefanetti, Giuseppe; MacLennan, Calman A